Mark Identification

ANTHARIS THERAPEUTICS

Serial Number

99222134

Filing Date

Jun 6, 2025

Trademark by

ANTHARIS THERAPEUTICS HOLDINGS INC.

Classification Information

Biologics in the nature of pharmaceutical preparations; Pharmaceutical and biological preparations for use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells

Pharmaceuticals

Custom manufacturing of therapeutic agents for use in pharmaceuticals

Treatment of Materials

Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology

Computer and Scientific